| |
|
|
|
HTG Molecular Diagnostics Inc.  
|
|
0.9424 0.012 (0.01%) |
08-23 16:00 |
|
Open: |
0.95 |
Pre close: |
0.93 |
Target:
|
1.53 
|
|
High: |
0.96 |
Low: |
0.92 |
Resistance:
|
1.31
1.55
|
|
Volume: |
208,798 |
Market Cap: |
25M |
Support:
|
0.92
0.77
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
0.96
|
MACD |
MACD(12,26):
|
-0.15  |
|
MA(20): |
1.15 |
Signal(12,26,9): |
-0.15 |
|
MA(100): |
1.92 |
Stochastic Oscillator |
%K(14,3):
|
6.87 |
|
MA(250): |
2.67 |
%D(3): |
8.70 |
|
Average Volume(K) |
3-Month: |
22495
|
52-Week |
High:
|
5.46 |
|
10-Days: |
18596 |
Low: |
0.92 |
|
RSI |
RSI(14):
|
24.62 |
Change(%): |
-72.2 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.600 |
Return on Equity (ttm) |
-88.2 |
Shares Out. (M) |
28.71 |
|
EPS Est. Current Year |
-2.290 |
Return on Assets (ttm) |
-25.1 |
Shares Float (M) |
22.00 |
|
EPS Est. Next Year |
-1.720 |
PEG Ratio |
0.00 |
% Held by Insiders |
7.75 |
|
EPS Est. Next Quarter |
-0.480 |
Qtrly Rev. Growth |
18.0 |
% Held by Institutions |
51.30 |
|
Forward EPS |
-0.720 |
Gross Profit (p.s.) |
0.139 |
Shares Short (K) |
3470 |
|
Book Value (p.s.) |
0.410 |
EBITDA (p.s.) |
-0.543 |
P/E |
-1.57 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
2.30 |
|
Profit Margin |
-79.96 |
Operating Cash Flow
(M) |
-14.93 |
P/S |
36075072.00 |
|
Operating Margin |
-78.82 |
Levered Free Cash Flow
(M) |
-7.92 |
P/CF |
-1.81 |
|
|
|
|
|
|
